|
TMEM14C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.373830E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.664830E-01 |
| Normal-vs-Stage2 |
3.661400E-01 |
| Normal-vs-Stage3 |
4.4064999999982E-05 |
| Normal-vs-Stage4 |
5.675700E-02 |
| Stage1-vs-Stage2 |
8.857800E-01 |
| Stage1-vs-Stage3 |
4.018900E-04 |
| Stage1-vs-Stage4 |
3.840000E-01 |
| Stage2-vs-Stage3 |
1.006990E-01 |
| Stage2-vs-Stage4 |
7.292200E-01 |
| Stage3-vs-Stage4 |
3.446400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.598600E-03 |
| Normal-vs-AfricanAmerican |
9.982200E-01 |
| Normal-vs-Asian |
2.620400E-01 |
| Caucasian-vs-AfricanAmerican |
9.166100E-02 |
| Caucasian-vs-Asian |
8.577200E-01 |
| AfricanAmerican-vs-Asian |
4.456600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.456900E-03 |
| Normal-vs-Female |
7.890000E-02 |
| Male-vs-Female |
4.116600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.513600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.478100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.381800E-02 |
| Normal-vs-Age(81-100Yrs) |
6.923000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.099400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.461000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.894800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.577400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.155000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.252000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.867400E-01 |
| Normal-vs-Grade 2 |
1.336230E-01 |
| Normal-vs-Grade 3 |
3.604400E-02 |
| Normal-vs-Grade 4 |
7.71210000000133E-05 |
| Grade 1-vs-Grade 2 |
5.676000E-01 |
| Grade 1-vs-Grade 3 |
4.507400E-01 |
| Grade 1-vs-Grade 4 |
5.279700E-02 |
| Grade 2-vs-Grade 3 |
4.714000E-01 |
| Grade 2-vs-Grade 4 |
1.061060E-03 |
| Grade 3-vs-Grade 4 |
1.226140E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.645800E-01 |
| Normal-vs-ccB subtype |
4.17580000000584E-05 |
| ccA subtype-vs-ccB subtype |
8.32320000000442E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.664300E-02 |
| Normal-vs-N1 |
2.666300E-02 |
| N0-vs-N1 |
3.374600E-01 |
|
|
